Work

A reply

Year: 2014
Type: letter
Abstract: We thank Drs Phan, Ngui and Cowie for their comments on our study 1. We agree entirely with many of the study limitations they highlight and believe that we reflected on these in our article. However, it is possible that they have misunderstood the context in which the study was performed. In the UK, the paradigm of stroke volume-guided fluid therapy has been imposed on anaesthetists, with financial incentives being awarded for ‘compliance’, an issue eruditely illuminated by Drs Stevenson and Stoker in their letter and with whom we entirely agree. While we recognise that caution must be applied when extrapolating to patient information gleaned from healthy volunteers, such healthy volunteer studies have been used to provide the physiological justification for stroke volume-guided fluid therapy; we believe our findings counter the previously cited evidence and reinforce that the ‘real life’ situation is far more complex. To study a specific physiological state (i.e. normovolaemia) requires a specific model with as few confounding/influencing factors as possible. To attempt to address such questions in a patient population introduces numerous variables that cannot be adequately controlled and thus the results become more confusing and even easier to criticise. The use of healthy volunteers provides a ‘clean’ methodological environment in which to ask such specific questions, but with the caveat that the ‘answers’ are more difficult to extrapolate. While Dr. Phan and colleagues correctly point out that we used intra-individual measurements to calculate sample size, we also used published data from critically ill patients (i.e. inter-individual measu-rements) in our calculations. Power calculations are always a challenge for pilot studies where existing data are not available; however, such calculations are essential in order to gain Research Ethics Committee approval in the UK. We believe that our use of published intra- and inter-individual data, together with our own intra-individual pilot data, was the most rigorous approach to estimating sample size. While it is possible that our findings occurred by chance (which we recognise in our article), we have stressed that our findings remain clinically significant, as variations such as this could occur when managing patients. We fully appreciate that echocardiography has limitations in interpreting stroke volume values; however, this is the case with all available stroke volume/cardiac output monitors, further emphasising that using such monitors as the sole guide to fluid management may not be the panacea suggested in current recommendations. We used transthoracic echocardiography as it was the most accurate and pragmatic tool to measure stroke volume in a cohort of volunteers and, as their citation suggests 2, is highly effective at detecting volume responsiveness. It would seem that Dr. Phan and colleagues fundamentally share our belief that assessing and managing ‘fluid status’ is complex, and we propose that the current recommendations guiding such therapy should be reviewed. We hope that our work will trigger further study into the physiological and pathophysiological volaemic states encountered clinically and manipulated with intravenous fluid therapy.
Source: Anaesthesia
Authors: J. M. Handy, G. E. P. Godfrey, S. Dubrey
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4232198883
Cites: 2
Cited by:
Related to: 10